High affinity bradykinin binding to human inflammatory cells

Biochemistry and Molecular Biology International

Volumn 43, Issue 2, 1997, Pages 279-290

  Rajasekariah, Poornima ^a   Warlow, Robert S ^a   Walls, Ronald S ^a  

^a NONE

Author keywords

BK analogues; Bradykinin; Neutrophils; PBMC; Radioligand binding

Indexed keywords

BRADYKININ; IODINE 125;

ARTICLE; COMPETITIVE INHIBITION; DISSOCIATION CONSTANT; HORMONE BINDING; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MONONUCLEAR CELL; NEUTROPHIL;

EID: 0031394914     PISSN: 10399712     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216549700204061     Document Type: Article

References (25)

1. Regoli, D. and Barabe, J. (1980) Pharmacological Reviews 32, 1-46.
2. Erdos, E.G. (1979) In Erdos, E.G. (ed.) Handb. Exp. Pharmacol. Springer-Verlag, Berlin, 25 (Suppl), pp. 427-487.
3. Mersey, J.H., Williams, G.H., Emanuel, R., Dluhy, R.G., Wong, P.Y. and Moose, T.J. (1979) J. Clin. Endocrinol. Metab. 48, 642-647.
4. Wunderer, G., Walter, I., Eschenbacher, B., Lang, M., Kellermann, J. and Kindermann, G. (1990) Biol. Chem. Hoppe-Seyler. 371, 977-981.
5. Llona, I., Vavrek, R., Stewart, J. and Huidobro-Toro, J.P. (1987) J. Pharmacol. Exp. Ther. 241, 608-614.
6. Braas, K.M., Manning, D.C., Perry, D.C. and Snyder, S.H. (1988) Br. J.Pharmacol. 94, 3-5.
7. Conclin, B.R., Burch, R.M., Steranka, L.R. and Axelrod, J. (1988) J. Pharmacol. Expt. Ther. 244, 646-649.
8. Plevin, R. and Owen, P.J. (1988). Trends Pharmacol. Sci. 9, 387-389.
9. Field, J.L., Hall, J.M. and Morton, I.K.M. (1992) Br. J. Pharmacol. 105, 293-296.
10. Nardone, J. and Hogan,P.G. (1994). Proc. Natl. Acad. Sci. USA 91, 4417-4421.
11. Ahluwalia, A. and Perretti, M. (1996) J. Immunol. 156, 269-274.
12. Bockmann, S. and Paegelow, I. (1995) Eur.J.Pharmacol. 291, 159-165.
13. Carl, V.S., Moore, E.E., Moore, F.A. and Whalley, E.T. (1996) Immunopharma. 33, 325-329.
14. Fredrick, M.J. and Odya, C.E. (1987) Eur. J. Pharmacol. 134, 45-52.
15. Snell, P.H., Gillian, E.P., Burgess, G.M., Snell, C.R. and Webb, W. (1990) Biochem. Pharmacol. 39, 1921-1928.
16. Faussner, A., Heinz-Erian, P., Klier, C., and Roscher A.A. (1991) J. Biol. Chem. 266, 9442-9446.
17. Trifilieff, A., Lach, E., Mousli, M., Haddad, E-B., Landry, Y. and Gies, J-P. (1994) Biochemica et Biophysica Acta 1191, 109-116.
18. Holloway, P.W. (1973) Anal. Biochem. 53, 304-308.
19. Warlow, R.S., White, R. and Bernard, C.C.A.(1986) Mol. Immunol. 23, 393-402.
20. Yaqoob, M. and Snell, C.R. (1994) J. Neurochem. 62, 17-26.
21. Scatchard, G. (1945) Ann.N.Y.Acad.Sci. 51, 660-672.
22. Manning, D.C., Vavrek, R., Stewart, J.M. and Snyder, S.H. J. (1986) Phrarmacol. Exptl. Therapeu. 237, 504-512.
23. Hurko, O. (1978) Arch. Biochem. Biophys. 190, 434-445.
24. Gorissen, H., Aerts, G., Ilien, B. and Laduron, P. (1981) Anal. Biochem. 111, 33-41.
25. Alla, S.A., Buschko, J., Quitterer, U., Maidhof, A., Haasemann, M., Breipohl, G., Knolle, J. and Muller-Esterl, W. (1993) J. Biol. Chem. 268, 17277-17285.